Research Center for Emerging Viral Infections, College of Medicine, Chang Gung Universitygrid.145695.a, Taoyuan, Taiwan.
Division of Infectious Diseases, Department of Pediatrics, Linkou Chang Gung Memorial Hospital, Taoyuan, Taiwan.
Microbiol Mol Biol Rev. 2022 Jun 15;86(2):e0002621. doi: 10.1128/mmbr.00026-21. Epub 2022 Mar 28.
Coronavirus disease 2019 (COVID-19) is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The global COVID-19 pandemic continues to threaten the lives of hundreds of millions of people, with a severe negative impact on the global economy. Although several COVID-19 vaccines are currently being administered, none of them is 100% effective. Moreover, SARS-CoV-2 variants remain an important worldwide public health issue. Hence, the accelerated development of efficacious antiviral agents is urgently needed. Coronavirus depends on various host cell factors for replication. An ongoing research objective is the identification of host factors that could be exploited as targets for drugs and compounds effective against SARS-CoV-2. In the present review, we discuss the molecular mechanisms of SARS-CoV-2 and related coronaviruses, focusing on the host factors or pathways involved in SARS-CoV-2 replication that have been identified by genome-wide CRISPR screening.
新型冠状病毒病(COVID-19)由严重急性呼吸综合征冠状病毒 2 型(SARS-CoV-2)引起。全球 COVID-19 大流行继续威胁着数亿人的生命,对全球经济造成严重负面影响。尽管目前正在接种几种 COVID-19 疫苗,但没有一种疫苗的有效率达到 100%。此外,SARS-CoV-2 变体仍然是一个重要的全球公共卫生问题。因此,迫切需要加速开发有效的抗病毒药物。冠状病毒依靠各种宿主细胞因子进行复制。正在进行的研究目标是鉴定宿主因子,这些宿主因子可以作为针对 SARS-CoV-2 的药物和化合物的靶点。在本综述中,我们讨论了 SARS-CoV-2 及相关冠状病毒的分子机制,重点介绍了通过全基因组 CRISPR 筛选鉴定的参与 SARS-CoV-2 复制的宿主因子或途径。